drugset
drugset / Trial / NCT05596006

Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia

NCT05596006 ↗

Phase 2 Completed 45 enrolled Gadjah Mada University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is assess the efficacy of ASIMOMMY® in increasing breast milk production in postpartum mothers.

Timeline

Start
2022-12-31
Primary completion
2023-03-24
Completion
2023-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject ASIMOMMY® Traditional medicine (herbal / TCM) 500 mg Oral
Comparator Domperidone Unknown 10 mg Oral

Indications

No indication recorded.